相关实验视频
Updated: Apr 11, 2026

09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
15.7K
在使用天然多糖和基于聚烯胺的纳米材料在纳米配方中的多面药物输送方面最近的进展
Paromita Dutta Choudhury1, Abu Md Ashif Ikbal2, Sourav Saha3
1Department of Pharmaceutics, Regional Institute of Pharmaceutical Science and Technology, Abhoynagar, Agartala, 799 005, India.
Current topics in medicinal chemistry
|October 30, 2024
概括
天然多糖为开发安全有效的纳米颗粒用于药物输送提供了可持续的解决方案. 本综述探讨了它们在纳米技术和各种应用中的绿色合成中的应用.
科学领域:
- 纳米技术和材料科学 材料科学
- 生物技术和制药科学 生物技术和制药科学
背景情况:
- 越来越多的疾病多样性需要药物输送系统的进步.
- 开发安全,具有成本效益和环保的纳米粒子配方至关重要.
- 在纳米粒子开发中,天然的多糖为合成材料提供了一个可持续的替代品.
研究的目的:
- 审查自然多糖源及其在纳米颗粒制剂中的应用.
- 探索基于聚烯胺的纳米材料与天然多糖一起.
- 突出自然多糖在绿色合成和更广泛的配方中的作用.
主要方法:
- 关于天然多糖源及其在纳米材料合成中的应用的文献综述.
- 基于聚烯胺的纳米材料与天然聚合物结合的分析.
- 检查基于多糖的纳米颗粒的各种制备方法.
主要成果:
- 天然多糖是多功能,用于创建安全,可持续的纳米颗粒.
- 这些材料可以减轻与合成纳米粒子相关的风险.
- 多糖在绿色合成和各种配方应用中具有价值.
结论:
- 天然多糖是推动药物输送可持续纳米技术的关键.
- 它们的应用范围超出了药物输送范围,影响了绿色化学.
- 对基于多糖的纳米材料的进一步研究有望提供创新的解决方案.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
98
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
98
Modified-Release Drug Delivery Systems: Rate-Programmed I
119
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
119
Modified-Release Drug Delivery Systems: Stimuli-Activated
126
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
126
Site-Targeted Drug Delivery Systems: Polymeric Carriers
117
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
117
Oral Drug Delivery Systems: Introduction
236
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
236
Oral Drug Delivery Systems: Delayed-Release Systems
155
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
155

